Fabry Disease Pipeline Market — Gene Therapy, Next-Generation...

blog ekledi Botanik

2026-06-18 10:07:30

Fabry Disease Pipeline Market — Gene Therapy, Next-Generation ERT, and the Race to Transform Rare Disease Treatment

Fabry disease — an X-linked lysosomal storage disorder caused by mutations in the GLA gene encoding alpha-galactosidase A (alpha-Gal A) — is a progressive multisystem condition affecting the heart, kidneys, nervous system, and skin through accumulation of globotriaosylceramide (Gb3) in cells throughout the body. With an estimated prevalence of approximately 1 in 40,000–100,000...

0 Yorumlar 0 Paylaşımlar 37 Görüntülenme 0 İncelemeler